The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), significantly improving access to diabetes treatment. The glucagon-like peptide-1 ...

Generic dapagliflozin is indicated to lower heart failure hospitalization risk in type 2 diabetes with established ...

According to the Company, the generic product will launch immediately. The Food and Drug Administration (FDA) has approved Liraglutide Injection, the first generic version of Victoza ®. Liraglutide is ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. For the first time, a generic GLP-1 has been approved by ...

Coverage of key CVD medications in low-cost generic drug programs in the United States differs by plan, medication type, and condition, according to an analysis published recently online in Annals of ...

The FDA approved the first generic dapagliflozin tablets, opening a competitive US market for pharma manufacturers and ...

Generic dapagliflozin is now approved for adults with type 2 diabetes, though current labeling excludes chronic kidney disease and pediatric use.

(RTTNews) - Teva Pharmaceutical Industries Ltd. (TEVA), Monday announced the launch of an authorized generic for Victoza injection with a quantity of 1.8 mg for type 2 diabetes patients in the U.S.

The U.S. Food and Drug Administration (FDA) has approved a generic daily injectable for the GLP-1 medication for patients who are 10 years old and up with Type 2 diabetes. The liraglutide injection, ...